Drug Trial Radar · NCT03852472
Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)
Last checked: Nov 20, 2026Latest source record: Mar 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
435
Actual
Start
Dec 21, 2018
Primary completion
Jan 14, 2021
Study completion Mar 9, 2021
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Feb 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 2 study of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa
Conditions
- Hidradenitis Suppurativa
- Acne Inversa
Interventions
AvacopanDrug
Active treatment
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12.Time frame: Baseline to Week 12
Locations
91 sites in 1 country. Site status is shown where the registry gives one.
Clinical Site
Birmingham, Alabama
Clinical Site
Birmingham, Alabama
Clinical Site
Mobile, Alabama
Clinical Site
Phoenix, Arizona
Clinical Site
Scottsdale, Arizona
Clinical Site
Fort Smith, Arkansas
Clinical Site
Rogers, Arkansas
Clinical Site
Fountain Valley, California
Clinical Site
Fremont, California
Clinical Site
Fullerton, California
Clinical Site
Huntington Beach, California
Clinical Site
Inglewood, California
Clinical Site
Los Angeles, California
Clinical Site
Los Angeles, California
Clinical Site
Los Angeles, California
Clinical Site
Manhattan Beach, California
Clinical Site
Newport Beach, California
Clinical Site
Northridge, California
Clinical Site
Redwood City, California
Clinical Site
Thousand Oaks, California
Clinical Site
Walnut Creek, California
Clinical Site
Boca Raton, Florida
Clinical Site
Clearwater, Florida
Clinical Site
Hialeah, Florida
Clinical Site
Hollywood, Florida
Clinical Site
Homestead, Florida
Clinical Site
Miami, Florida
Clinical Site
Miami, Florida
Clinical Site
Miami, Florida
Clinical Site
Ocala, Florida
Clinical Site
Orlando, Florida
Clinical Site
Pembroke Pines, Florida
Clinical Site
Tampa, Florida
Clinical Site
Tampa, Florida
Clinical Site
Tampa, Florida
Clinical Site
Weston, Florida
Clinical Site
Atlanta, Georgia
Clinical Site
Marietta, Georgia
Clinical Site
Newnan, Georgia
Clinical Site
Sandy Springs, Georgia
Showing 40 of 91 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.